MHC class Ib-restricted CD8+ T cells possess strong tumoricidal activities
Qing Li1, Liangyu Lin1, Peishun Shou1
1Chinese Academy of Sciences Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Summary
Major histocompatibility complex (MHC) class Ia primes CD8+ T cells, enhancing their ability to fight tumors. These primed cells resist exhaustion and effectively eliminate cancer without harming healthy tissues.
Area of Science:
- Immunology
- Cancer Biology
- T cell research
Background:
- Classical CD8+ T cells are crucial for tumor eradication.
- The role of MHC class Ib-restricted CD8+ T cells in anti-tumor immunity is not well understood.
Purpose of the Study:
- To investigate the anti-tumor activity of MHC class Ib-restricted CD8+ T cells.
- To explore the priming mechanisms and therapeutic potential of these cells.
Main Methods:
- Characterization of CX3CR1-expressing MHC class Ib-restricted CD8+ T cells.
- Assessment of their cytotoxic factors and resistance to exhaustion.
- Investigation of priming by MHC class Ia molecules in vitro and in vivo using mouse models.
- Identification of similar T cell populations in wild-type mice and human melanoma patients.
Main Results:
- CX3CR1+ MHC class Ib-restricted CD8+ T cells exhibit potent anti-tumor activity.
- MHC class Ia primes these cells for optimal, Tbet-dependent activation without allogeneic activation.
- Adoptive transfer of these primed cells inhibited tumor progression in mice without causing damage to normal tissues.
- A comparable population of tumoricidal cells was found in humans.
Conclusions:
- MHC class Ia plays a critical role in priming CD8+ T cells for effective anti-tumor immunity.
- MHC class Ib-restricted CD8+ T cells represent a promising therapeutic target for cancer treatment.
- This research highlights a novel mechanism for enhancing anti-tumor immune responses.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
933
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
933
01:27Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
01:22T Cell Activation and Clonal Selection
764
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
764
01:26Antigens Involved in Adaptive Immunity
511
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
511
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:28Cells of the Innate Immune Response
1.7K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.7K